当前位置:首页 - 行情中心 - 振东制药(300158) - 财务分析 - 现金流量表

振东制药

(300158)

  

流通市值:47.20亿  总市值:47.23亿
流通股本:9.92亿   总股本:9.92亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,512,966,001.181,019,135,366.49461,491,033.722,580,213,730.06
  收到的税费返还8,000,0004,009,856.744,000,00023,352,697.14
  收到其他与经营活动有关的现金27,685,829.6216,668,103.7211,874,428.3728,052,239.73
  经营活动现金流入小计1,548,651,830.81,039,813,326.95477,365,462.092,631,618,666.93
  购买商品、接受劳务支付的现金579,980,432.66422,298,068.57225,753,203.491,246,258,685.43
  支付给职工以及为职工支付的现金397,836,585.36278,162,766.84135,217,681.3537,330,984.65
  支付的各项税费74,548,645.9961,618,780.3320,017,692.57182,355,521.35
  支付其他与经营活动有关的现金821,769,342.54625,625,290.46400,438,761.161,126,153,202.31
  经营活动现金流出小计1,874,135,006.551,387,704,906.2781,427,338.523,092,098,393.74
  经营活动产生的现金流量净额-325,483,175.75-347,891,579.25-304,061,876.43-460,479,726.81
二、投资活动产生的现金流量:
  收回投资收到的现金2,525,000,0001,308,211,646.12597,000,0003,012,919,600
  取得投资收益收到的现金10,036,257.046,645,931.582,862,868.1712,867,180.86
  处置固定资产、无形资产和其他长期资产收回的现金净额---59,947.13
  投资活动现金流入小计2,535,036,257.041,314,857,577.7599,862,868.173,025,846,727.99
  购建固定资产、无形资产和其他长期资产支付的现金73,547,673.435,744,130.9719,561,814.41179,124,007.07
  投资支付的现金2,479,000,0001,309,000,000673,000,0002,550,022,200
  投资活动现金流出小计2,552,547,673.41,344,744,130.97692,561,814.412,729,146,207.07
  投资活动产生的现金流量净额-17,511,416.36-29,886,553.27-92,698,946.24296,700,520.92
三、筹资活动产生的现金流量:
  取得借款收到的现金298,384,300148,664,633.58148,384,300162,158,486.5
  收到其他与筹资活动有关的现金8,455,412.36,713,553.443,509,752.0436,455,079.65
  筹资活动现金流入小计306,839,712.3155,378,187.02151,894,052.04198,613,566.15
  偿还债务支付的现金100,100,000--33,965,173.03
  分配股利、利润或偿付利息支付的现金4,370,930.82,559,475.111,008,244.37713,077.28
  支付其他与筹资活动有关的现金5,458,275.374,544,411.121,735,783.6266,303,513.23
  筹资活动现金流出小计109,929,206.177,103,886.232,744,027.99100,981,763.54
  筹资活动产生的现金流量净额196,910,506.13148,274,300.79149,150,024.0597,631,802.61
五、现金及现金等价物净增加额-146,084,085.98-229,503,831.73-247,610,798.62-66,147,403.28
  加:期初现金及现金等价物余额491,867,869.21491,867,869.21491,867,869.21558,015,272.49
  期末现金及现金等价物余额345,783,783.23262,364,037.48244,257,070.59491,867,869.21
补充资料:
  净利润--95,301,962.62--303,086,623.19
  资产减值准备-40,387,090.48-5,597,299.55
  固定资产和投资性房地产折旧-44,795,261.37-89,075,688.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-44,795,261.37-89,075,688.96
  无形资产摊销-12,592,606.39-25,508,052.43
  长期待摊费用摊销-9,716,902.53-11,851,010.56
  处置固定资产、无形资产和其他长期资产的损失---633,441.94
  固定资产报废损失-4,120.52-143,074.28
  公允价值变动损失--251,967.83--1,586,150.58
  财务费用-3,027,189.96-2,207,915.59
  投资损失--330,970.02--10,781,530.12
  递延所得税--3,102,430.12--3,015,355.81
  其中:递延所得税资产减少--2,118,158.19--3,160,732.42
    递延所得税负债增加--984,271.93-145,376.61
  存货的减少-28,909,950.33-237,151,549.57
  经营性应收项目的减少-70,290,576.27--164,535,938.25
  经营性应付项目的增加--458,255,174.82--347,966,034.3
  其他--1,074,585.98--3,086,630.07
  现金的期末余额-262,364,037.48-491,867,869.21
  减:现金的期初余额-491,867,869.21-558,015,272.49
  现金及现金等价物的净增加额--229,503,831.73--66,147,403.28
公告日期2026-10-272026-08-262026-04-212026-04-21
审计意见(境内)标准无保留意见
TOP↑